Answers are grounded in this paper and cite their sources.
Human papillomavirus (HPV) infection represents a major global public health burden. Despite the availability of effective vaccines, clear national policies on HPV vaccination remain absent in Iran. Understanding current HPV vaccine coverage and the factors influencing vaccine acceptance among Iranian adults is essential for guiding effective public health interventions. This cross-sectional study was conducted in 2025 using an online survey of Iranian adults. We utilized the newly developed Iranian HPV Vaccine Determinants Scale (I-HPV-VDS), which was constructed based on well-established health behavior frameworks. Psychometric assessment of the questionnaire included using face validity, construct validity, and Cronbach’s alpha. Post-stratification weighting was applied using national distributions of age, gender and educational attainment to improve population representativeness. Univariate and multivariable logistic regression analyses were used to identify determinants of HPV vaccine uptake. In the weighted sample of 1416 Iranian adults, HPV vaccine uptake was 5.5%. Vaccine uptake was significantly higher among younger adults (aOR: 2.88, 95% CI: 1.52–5.47), females (aOR: 5.90, 95% CI: 3.09–11.26), and unmarried individuals (aOR: 16.72, 95% CI: 7.64–36.57), particularly those previously married or in non-marital relationships. Each one standard deviation increase in Social Support and Self-efficacy was associated with nearly 4 times higher odds of uptake (aOR: 4.46, 95% CI: 2.43–8.18), while Risk Perception was associated with about 2 times higher odds (aOR: 2.12, 95% CI: 1.27–3.52). Interestingly, stigma-related and behavioral concern components were not independently associated with vaccination in multivariable analysis. It is of note that the wide CIs observed for several subgroups likely reflect very low event counts in specific strata combined with post-stratification weighting, which warrants cautious interpretation of these findings. The critically low HPV vaccination uptake, particularly in men, alongside profound social inequities suggest a need to consider measures to improve access, including possible inclusion of the HPV vaccine in the national immunization program. Furthermore, considering recent HPV vaccination initiatives in neighboring countries and the central role of HPV vaccination in global cervical cancer elimination efforts, strengthening public understanding of HPV susceptibility and vaccine effectiveness, as well as enhancing supportive social environments within the Iranian context is essential.
No takes yet. Share an insight, caveat, or question.
Askarian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: